Antihypertensive drug Valsartan promotes dendritic spine density by altering AMPA receptor trafficking.

Abstract

Recent studies demonstrated that the antihypertensive drug Valsartan improved spatial and episodic memory in mouse models of Alzheimer's Disease (AD) and human subjects with hypertension. However, the molecular mechanism by which Valsartan can regulate cognitive function is still unknown. Here, we investigated the effect of Valsartan on dendritic spine formation in primary hippocampal neurons, which is correlated with learning and memory. Interestingly, we found that Valsartan promotes spinogenesis in developing and mature neurons. In addition, we found that Valsartan increases the puncta number of PSD-95 and trends toward an increase in the puncta number of synaptophysin. Moreover, Valsartan increased the cell surface levels of AMPA receptors and selectively altered the levels of spinogenesis-related proteins, including CaMKIIα and phospho-CDK5. These data suggest that Valsartan may promote spinogenesis by enhancing AMPA receptor trafficking and synaptic plasticity signaling.

DOI: 10.1016/j.bbrc.2013.08.091
050100201520162017
Citations per Year

Citation Velocity: 12

Averaging 12 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Sohn2013AntihypertensiveDV, title={Antihypertensive drug Valsartan promotes dendritic spine density by altering AMPA receptor trafficking.}, author={Young In Sohn and Nathanael J Lee and Andrew S Chung and J M Saavedra and Raymond Scott Turner and Daniel T. S. Pak and Hyang-Sook Hoe}, journal={Biochemical and biophysical research communications}, year={2013}, volume={439 4}, pages={464-70} }